enzastaurin

First patient dosed in unique biomarker guided Ph III study of enzastaurin + R-CHOP in high-risk diffuse large B-cell lymphoma (DLBCL)
CP Wire
Wed, 04/4/18 - 09:53 am
biomarkers
enzastaurin
Denovo Therapeutics
DLBCL
R-CHOP
Denovo Biopharma Acquires Late-Stage Oncology Drug From lilly For Development As A Personalized Medicine
Yahoo
Tue, 09/16/14 - 01:42 pm
DeNovo
Eli Lilly
personalized medicine
enzastaurin
This Week in Biotech
Motley Fool
Sun, 05/12/13 - 11:02 am
GSK
Theravance
Breo Ellipta
Pain Therapeutics
Durect
Pfizer
Remoxy
Eli Lilly
enzastaurin
Eli Lilly's lymphoma drug fails in late-stage trial
Reuters
Fri, 05/10/13 - 08:56 am
lymphoma
enzastaurin
Eli Lilly